澳门五洲药物国际贸易有限公司

What 澳门五洲药物国际贸易有限公司 does

Wuzhou Drug International Trading Limited (澳门五洲药物国际贸易有限公司), operating under the trade name WuZhou Drug / Wuzhou Pharmaceutical, is a Macau-incorporated pharmaceutical import-export, registration, and distribution company that helps overseas pharmaceutical firms enter the Greater China and Southeast Asian markets. The company manages a portfolio of more than 300 product lines sourced from over 70 countries, including specialty and branded-generic medicines such as Tyrvaya (dry-eye nasal spray), Defal (DMD muscular dystrophy), Venosmil (chronic venous insufficiency), Alginos (reflux), LiveSpo Colon (spore probiotic), BRIX 3000 (non-invasive caries removal), StroVac (recurrent UTI prophylaxis), Axhidrox (hyperhidrosis), and the Fitostimoline wound-care line from Italy. Core operational capabilities center on temperature-controlled cold-chain logistics (door-to-door wireless temperature monitoring across deep-frozen, 2–8°C, 2–25°C, and 15–25°C ranges), clinical-trial comparator sourcing, pharmacovigilance, and one-stop compliance documentation including endangered-species, narcotic/psychotropic, and dangerous-goods certifications.

The business model combines transaction-based revenue from wholesale and distribution of branded generic and specialty medicines (including market shortages and unlicensed/unlicensed medicines for named-patient and compassionate use) with professional-services fees for overseas drug registration, cross-border e-commerce settlement on JD International and Tmall Global, and clinical trial supply. Go-to-market is sales-led, targeting overseas pharma companies seeking China entry and Chinese R&D organizations needing reference listed drugs, BE reagents, and comparator products; distribution flows through pharmacy networks, hospitals, and cross-border e-commerce platforms across Macau, Hong Kong, mainland China, and Southeast Asia. The company holds Macau wholesaler license No. 289, narcotic/psychotropic import-export approval, drug transshipment license No. 02/2019, and Class I/III dangerous-goods transport certification, and operates a third-party logistics partnership with DHL China. The company is privately held, founder-owned, with no disclosed funding rounds, parent company, headcount, or revenue.

Name

澳门五洲药物国际贸易有限公司

Legal name

Wuzhou Drug International Trading Limited (五洲藥物國際貿易有限公司)

Website

https://droga.cn

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Wuzhou Drug International Trading Limited is a Macau-based pharmaceutical import/export and distribution company that helps overseas pharmaceutical firms register, distribute, and sell specialty and branded-generic medicines across Greater China and Southeast Asia via pharmacies, hospitals, and cross-border e-commerce.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale & Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Full-Line Pharmaceutical Wholesalers (HLAIAJAA), Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL), Pharmaceutical & Biologics Courier (Rx, Specialty Drugs) (TLAAAIAB)

Keywords

• Pharmaceutical wholesale
• Drug distribution services
• Pharmaceutical import export
• Clinical trial comparator supply
• Drug registration services

Headquarters

HQ city

Macau

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Wholesale and Distribution: Wholesale and distribution of branded generic and specialty medicines, including market shortages and unlicensed/unregistered medicines for named patient/compassionate procurement/emergency healthcare needs.
2. Drug Registration Services: Providing overseas drug registration services for global pharmaceutical companies in Greater China and Southeast Asia, including medical device registration.
3. Cross-border E-commerce Settlement: Assisting overseas pharmaceutical companies to quickly enter China's cross-border e-commerce platforms (JD International and Tmall Global), providing one-stop services from registration to distribution.
4. Clinical Trials Supply: Sourcing and supply of commercial medicines/comparators for clinical trials across all therapeutic areas, including specialty medicines under Special Access Program.
5. Research Supplies Procurement: Procurement of listed drugs, reference drugs, BE experimental reagents, control drugs for pharmaceutical research, new drug research and drug registration required samples or control drugs.
6. One-time Import Compliance Solutions: Providing global drug origin certificates, export certificates, MSDS, COA, TSE/BSE, test reports and other documentation materials.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels3 records

Core offering

Wuzhou Drug International Trading Limited provides pharmaceutical wholesale and distribution of branded generic and specialty medicines sourced from over 70 countries, alongside overseas drug registration services in Greater China and Southeast Asia. The company also facilitates rapid entry into China's cross-border e-commerce platforms (JD International, Tmall Global) and supplies clinical trial comparators and reference listed drugs with temperature-controlled cold-chain logistics.

Product overview

Wuzhou Drug International Trading Limited is a pharmaceutical import/export and distribution company specializing in international drug distribution, wholesale, and registration services. The company manages a portfolio of over 300 product lines sourced from more than 70 countries. Their core offerings include branded generic and specialty medicines for clinical trial supplies, wholesale/distribution, and cross-border e-commerce entry into the Chinese market. The company represents and distributes products including Tyrvaya (dry eye nasal spray), Defal (DMD treatment), Venosmil Capsulas (venous insufficiency treatment), Alginos (gastrointestinal product), Dynamogen (pediatric supplement), LiveSpo Colon (probiotic), BRIX 3000 (dental product), StroVac (urinary tract infection prophylaxis), Axhidrox (hyperhidrosis treatment), and Fitostimoline wound care products. Services span drug registration in Greater China and Southeast Asia, specialty medicines sourcing, clinical supply management, and logistics support including temperature-controlled transport. The company holds licenses for drug wholesale (number 289) and import/export of narcotic and psychotropic substances in Macau.

Differentiator

Problem solved

Functional benefit

Products and services

• Tyrvaya World's first nasal spray for stimulating natural tear secretion, intended for dry eye treatment with innovative mechanism, long-lasting therapeutic effects, and convenient daily use.
• Defal (Defal Oral Liquid and Defal Tablets) Pharmaceutical product with two dosage forms (oral liquid and tablets) used for treatment of Duchenne muscular dystrophy (DMD); positioned as an irreplaceable drug for DMD.
• Venosmil Capsulas (Venosmil) Diosmin derivative, semi-synthetic flavonoid drug used to reduce venous edema and treat varicose ulcers; preferred treatment for chronic lower limb venous insufficiency in Spain and European countries.
• Alginos Gastrointestinal product composed of alginate, calcium carbonate, and sodium bicarbonate that neutralizes gastric acid and prevents reflux, forming a foam latex protective layer for gastrointestinal health.
• Dynamogen Nutritional supplement that improves appetite loss, increases nutrient absorption, promotes children's development, enhances immune function, and maintains mental energy.
• LiveSpo Colon Liquid spore probiotic product using innovative spore-forming bacteria technology that survives acidic environments and almost 100% in the gut, supporting intestinal health and immune function.
• BRIX 3000 Dental product based on enzyme technology for non-invasive caries removal; harmless water-based gel that eliminates the need for anesthetics and reduces turbine use, safe for all patients including young children and pregnant women.
• StroVac/Booster-Strovac Effective and long-lasting non-antibiotic prophylactic drug for recurrent urinary tract infections (rUTI); easy to administer with low incidence of adverse events, reducing frequency of UTIs and antibiotic use.
• Axhidrox (Axhidor) Topical cream for hyperhidrosis approved for sale in 11 countries; main ingredient is glucuronium bromide, an anticholinergic drug that reduces sweat formation by slowing nerve impulse transmission to sweat glands.
• 0.01% Atropine Eye Drops Low-concentration atropine eye drops for myopia control in children; 60% effective in delaying myopia progression, available in Macau, with CFDA registration under way in China.
• Drug Import and Export (Wholesale & Distribution) Wholesale and distribution of branded generic and specialty medicines for overseas pharmaceutical companies entering Greater China and Southeast Asia, with named-patient, compassionate, and emergency healthcare procurement for market shortages and unlicensed/unregistered medicines.
• Drug Registration Service Provides overseas drug registration services in Greater China and Southeast Asia for global pharmaceutical companies, with over 40 products successfully registered.
• Drug Distribution Service Large sales team distributing drugs in Greater China and Southeast Asia via pharmacy networks, hospital channels, and cross-border e-commerce platforms.
• Cross-Border E-commerce Settlement Service Assists overseas pharmaceutical companies to quickly enter China's cross-border e-commerce platforms such as JD International and Tmall Global, providing one-stop services from registration to distribution.
• Clinical Trial Comparator and Reference Listed Drug Supply Sourcing and supply of commercial medicines and comparator drugs for clinical trials across all therapeutic areas, including specialty medicines under Special Access Program, with access to products meeting various strengths, batch numbers, expiry dates, and language documentation.
• High Standard Logistics (Temperature-Controlled Cold Chain) Pharmaceutical logistics service with wireless sensor monitoring for door-to-door transit; passive and active temperature-controlled packaging solutions for deep frozen, 2-8°C, 2-25°C, and 15-25°C temperature ranges; global care team operating 24 hours a day, 365 days a year.
• Pharmacovigilance Service Collecting, processing, and evaluating information related to product benefit-risk profiles for marketed or clinical-development products, with timely communication of safety issues to medical professionals, patients, and regulatory agencies.
• One-time Import Compliance Solutions Provides global drug origin certificates, export certificates, MSDS, COA, TSE/BSE, test reports, and other documentation materials required for one-time pharmaceutical import compliance.

Quantifiable outcome

• Successfully registered over 40 products
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• DHL ChinacoreStrategic or Co-development Partner · 19 July 2019Partnership for third-party logistics, warehousing, distribution and value-added services related to medicines, health products and medical devices. Wuzhou Pharmaceuticals obtained drug transfer transshipment license (No. 02/2019) and immediately signed cooperation agreement with DHL China to jointly expand logistics business.
• Various Pharmaceutical Suppliers (Europe, US, Japan, Southeast Asia)coreChannel Partner/ Reseller/ DistributorLong-term partnerships with pharmaceutical suppliers from Europe, US, Japan, and Southeast Asia. Wuzhou Drug acts as their Chinese agent, importing and distributing their products in Greater China and Southeast Asian markets.
• Medicines.org.uk (UK Medicines Information)minorOthersListed as a regulatory reference resource on the company website, suggesting alignment with UK pharmaceutical information standards.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Marken (UPS Healthcare): Marken, part of UPS Healthcare, specializes in clinical trial material sourcing, storage, and global distribution along with direct-to-patient services; competes head-to-head with Wuzhou's clinical supply and pharmaceutical logistics offering.
• World Courier (Cencora/AmerisourceBergen): World Courier is the global specialty pharmaceutical logistics and clinical trial supply arm of Cencora, providing GDP-compliant cold-chain transport and comparator drug sourcing — directly comparable to Wuzhou's clinical supply, comparator sourcing, and temperature-controlled distribution services.
• DHL Supply Chain (Life Sciences & Healthcare): DHL's Life Sciences and Healthcare division provides GDP-compliant warehousing and global pharma distribution; DHL is Wuzhou's named logistics partner and an obvious reference benchmark for its wholesale-plus-3PL model.
• Zuellig Pharma: Zuellig Pharma is one of the largest specialty pharmaceutical distributors in Asia, providing importation, registration, and distribution services across Greater China and Southeast Asia — the exact geographies Wuzhou targets.
• DKSH Holding: DKSH's Healthcare unit offers market expansion services for pharmaceutical and consumer health companies across Asia, including importation, registration, and distribution — directly paralleling Wuzhou's registration-to-distribution play.

Broad incumbents

• Bolloré Logistics (Healthcare): Bolloré Logistics' Healthcare division offers worldwide GDP-compliant pharma transport and clinical trial supply, comparable to Wuzhou's clinical supply and specialty medicine distribution services for global customers.
• Sinopharm Group (国药控股): Sinopharm is China's largest pharmaceutical wholesaler and distributor with nationwide distribution and import capability; it is the dominant incumbent across the same wholesale and import-export value chain Wuzhou operates in.
• Kerry Logistics Network: Kerry Logistics operates an Asia-wide pharmaceutical and cold-chain logistics network; comparable to Wuzhou's regional healthcare logistics capability and to its partnership model with DHL.
• Shanghai Pharmaceuticals Holding (上海医药): Shanghai Pharmaceuticals is a leading Chinese pharmaceutical manufacturer and distributor with nationwide distribution and import/export operations; a major incumbent that competes with Wuzhou in distribution and import channels.

Regional players

• SF Intra-city / SF Supply Chain Pharmaceutical: SF International's pharmaceutical logistics arm provides cold-chain distribution for imported drugs into China, primarily serving Mainland China rather than the Macau/Greater China cross-border model that Wuzhou operates from; a regional peer with overlapping capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E6%BE%B3%E9%97%A8%E4%BA%94%E6%B4%B2%E8%8D%AF%E7%89%A9%E5%9B%BD%E9%99%85%E8%B4%B8%E6%98%93%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 澳门五洲药物国际贸易有限公司